We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MEDIX BIOCHEMICA AB

Develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry, as... read more Featured Products: More products

Download Mobile App





Medix Biochemica Celebrates Launch of New Molecular Diagnostic Reagents Division at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021

Medix Biochemica (Espoo, Finland) celebrated the launch of its new molecular diagnostic reagents division, MedixMDx at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany. More...

Medix, including Lee Biosolutions, EastCoast Bio and Diaclone, is a leading global supplier of critical raw materials used for in vitro diagnostics (IVD). Medix recently acquired Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology, and immunology. At MEDICA 2021, Medix showcased its wide portfolio of monoclonal antibodies, antigens for immunoassay materials, molecular diagnostics reagents, enzymes for clinical chemistry controls, and biochemicals and biological.

Medix highlighted its range of quality reagents offered through MedixMDx in combination with a host of custom services to provide IVD kit manufacturers, labs and research institutions with the tailored support they need from proof-of-concept right through to release for sale. In addition to highlighting its wide range of high-quality reagents and master mixes designed to shorten development timelines and work with various assay technologies, Medix also threw light on its technical support provided to clients as they develop their assays as well as contract manufacturing services.

Medix highlighted its broad range of platform-agnostic reagents, including enzymes, nucleic acid extraction products, buffers and as well as consumables. The company showcased its range of enzymes, ready mixes, controls, clinical specimens and general reagents in the areas of PCR/qPCR, isothermal nucleic acid amplification technologies (iNAAT), Next generation Sequencing (NGS).

Related Links:
Medix Biochemica 


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
Chlamydia Pneumoniae Test
Chlamydia Pneumoniae (CP) Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.